- Home
- VTGN
as of 12-02-2025 2:13pm EST
$3.85
$0.58
-13.13%
Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.
Chart Type:
Time Range:
| Founded: | 1998 | Country: | United States |
| Employees: | N/A | City: | SOUTH SAN FRANCISCO |
| Market Cap: | 122.1M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 742.7K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.92 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.90 - $5.14 | Next Earning Date: | 11-13-2025 |
| Revenue: | $721,000 | Revenue Growth: | -17.69% |
| Revenue Growth (this year): | 9.14% | Revenue Growth (next year): | 467.87% |
AI-Powered VTGN Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated 20 hours ago
AI Recommendation
hold
Model Accuracy: 70.39%
70.39%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Latest VistaGen Therapeutics Inc. News
VTGN Breaking Stock News: Dive into VTGN Ticker-Specific Updates for Smart Investing
Business Wire
Vistagen Appoints Nick Tressler as Chief Financial Officer
📈
AI Sentiment
Highly Positive
8/10
Business Wire
Vistagen Reports Findings on PH80’s Brain and Autonomic Effects in Women with Menopausal Hot Flashes at The Menopause Society 2025 Annual Meeting
📈
AI Sentiment
Highly Positive
8/10
Compare VTGN vs Leading Stocks
See how VTGN stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "VTGN VistaGen Therapeutics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.